News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
148 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (25661)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Business
Trailblazer in Molecular Genetics and Neuroscience, Jeremy Nathans, MD, PhD, to Advise Cerevance
Cerevance announced that Jeremy Nathans, M.D., Ph.D., has joined the company as a senior-level scientific advisor.
October 24, 2017
·
3 min read
Business
Lilly Exploring Sale, IPO of Animal Health Biz
Lilly’s Elanco animal health business is facing increased competition.
October 24, 2017
·
54 min read
Medicenna Solidifies Superkine Platform With Additional U.S. Patent Issuance
Medicenna today announced that the U.S. Patent and Trademark Office issued another patent related to the Company’s Superkine platform. U.S. Patent 9,738,696.
October 24, 2017
·
4 min read
Medicrea Launches UNiD HUB Proprietary Surgical Planning Through Machine Learning at NASS 2017
MEDICREA announced today that the Company will launch their UNiD HUB software at the 32nd Annual Meeting of the North American Spine Society (NASS), held October 25-28, 2017 in Orlando, Florida.
October 24, 2017
·
3 min read
Sequana Medical Announces Results of the MOSAIC Trial Data Presented at 2017 AASLD
Sequana Medical today announced that Prof. Florence Wong, University of Toronto, presented the findings of the MOSAIC study data at the Annual Meeting of the AASLD Annual Meeting , held in Washington, DC.
October 24, 2017
·
4 min read
Deals
Bracket Acquires mProve Health to Radically Advance Patient Engagement in Clinical Trials
Bracket today announced the strategic acquisition of mProve, a leading provider of mobile technologies for life science companies.
October 24, 2017
·
4 min read
Business
Ionis Pharmaceuticals to Hold Third Quarter 2017 Financial Results Webcast
Ionis Pharma announced today that it will host a live webcast on Tuesday, November 7 at 11:30 a.m.
October 24, 2017
·
3 min read
LDRA Clears Medical Device Manufacturers’ Path to IEC 62304 Compliance for Safe and Secure Medical Device Applications
LDRA announced LDRA tool suite for Medical Devices, a variant of its leading LDRA tool suite specifically tailored to help companies achieve IEC 62304 compliance and faster development of safety- and security-critical medical device applications.
October 24, 2017
·
5 min read
Drug Development
Biohaven Receives FDA May Proceed Letter for Phase 2/3 Clinical Trial of Trigriluzole in Patients with Obsessive-Compulsive Disorder
Biohaven and its wholly owned subsidiary, Biohaven Pharma, today announced that the FDA has notified the Company that it may proceed with its clinical investigation of trigriluzole, a novel glutamate modulator, as a potential treatment for patients with OCD.
October 24, 2017
·
5 min read
Business
Sobi Establishes New Leadership Structure and Appoints Torbjörn Hallberg as General Counsel
Swedish Orphan AB today announces the establishment of a new leadership structure; Executive Committee, to replace the Executive Leadership Team in its current form.
October 24, 2017
·
2 min read
Previous
2 of 15
Next